Theseus Pharmaceuticals Inc logo

Theseus Pharmaceuticals Inc

NAS:THRX (USA)  
1
$ 2.80 -0.01 (-0.36%) 11:09 PM EST
P/E:
At Loss
P/B:
0.53
Market Cap:
$ 122.09M
Enterprise V:
$ -82.35M
Volume:
57.87K
Avg Vol (2M):
247.41K
Volume:
57.87K
Market Cap $:
122.09M
PE Ratio:
At Loss
Avg Vol (2M):
247.41K
Enterprise Value $:
-82.35M
PB Ratio:
0.53

Business Description

Description
Theseus Pharmaceuticals Inc is a biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development and commercialization of transformative targeted therapies. The company's development programs are designed to address drug resistance mutations in key driver oncogenes, which are mutated genes that cause cancer.
Name Current Vs Industry Vs History
Cash-To-Debt 55.26
Equity-to-Asset 0.96
Debt-to-Equity 0.02
Debt-to-EBITDA -0.06
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -50.1
3-Year EPS without NRI Growth Rate -29.5
3-Year FCF Growth Rate -29.1

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 13.95
9-Day RSI 24.46
14-Day RSI 29.24
6-1 Month Momentum % -62.75
12-1 Month Momentum % -53.23

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 27.83
Quick Ratio 27.83
Cash Ratio 27.1

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -48.1
Shareholder Yield % 0.13
Name Current Vs Industry Vs History
ROE % -25.49
ROA % -24.27
ROIC % -323.9
ROC (Joel Greenblatt) % -1392.8
ROCE % -28.64

Financials (Next Earnings Date:2023-11-03 Est.)

THRX's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:THRX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Theseus Pharmaceuticals Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -1.41
Beta 0
Volatility % 211.3
14-Day RSI 29.24
14-Day ATR ($) 0.151749
20-Day SMA ($) 3.026
12-1 Month Momentum % -53.23
52-Week Range ($) 2.62 - 14.7672
Shares Outstanding (Mil) 43.6

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Theseus Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

Theseus Pharmaceuticals Inc Stock Events

Event Date Price($)
No Event Data

Theseus Pharmaceuticals Inc Frequently Asked Questions

What is Theseus Pharmaceuticals Inc(THRX)'s stock price today?
The current price of THRX is $2.80. The 52 week high of THRX is $14.77 and 52 week low is $2.62.
When is next earnings date of Theseus Pharmaceuticals Inc(THRX)?
The next earnings date of Theseus Pharmaceuticals Inc(THRX) is 2023-11-03 Est..
Does Theseus Pharmaceuticals Inc(THRX) pay dividends? If so, how much?
Theseus Pharmaceuticals Inc(THRX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1